Frost & Sullivan announced today that it recognized RapidAI with its 2022 Global Technology Innovation Leadership Award.
RapidAI develops artificial intelligence (AI) algorithms for treating vascular and neurovascular conditions. It offers solutions for stroke diagnosis and triage. Its AI creates high-quality, advanced brain images from non-contrast CT, CT angiography, CT perfusion and MRI diffusion and perfusion studies.
Frost & Sullivan said in a news release that the company “refined its holistic approach to care for life-threatening neurovascular and vascular conditions.” It continues to build a comprehensive software platform aimed to bridge the gaps in care.
The RapidAI platform offers value to a number of hospital environments and applications. Its technology can be used across emergency departments and trauma centers to acute stroke-ready hospitals, primary stroke centers and comprehensive stroke centers.
RapidAI designed its technology to improve diagnostic accuracy, ensure care team coordination and bring value to customers. It allows for the early identification of suspected stroke and expedites triage and transfer decisions.
“By automating and optimizing the entire workflow, from pre-hospital to the patient care pathway, RapidAI can save hospitals time and money, improve outcomes, and enable faster intervention,” said Pavel Zhebrouski, Frost & Sullivan best practices research analyst. “The AI-based solution allows comprehensive stroke center care teams to connect quickly with the primary stroke centers before patient transfer and prepare for the proper intervention.”
The platform helps care teams save time while communicating and updating patient status. It offers messaging, new case notifications and rapid results delivery.
“The RapidAI platform has clinical decision support modules, patient care workflow solutions, and analytic insights for various diseases. It changes the paradigm of stroke care and supports other disease areas for better patient outcomes,” said Dr. Eishita Pal, a Frost & Sullivan industry analyst. For its strong overall performance, RapidAI earns Frost & Sullivan’s 2022 Global Technology Innovation Leadership Award in the artificial intelligence algorithms for the stroke market.